Updated Mar. 7, 2013 at 10:35 a.m.
Research Triangle Park, N.C. — GlaxoSmithKline's top executive Andrew Witty and the drug giant's chief financial officer take substantial reductions in compensation for 2012 as European market woes take a bite from GSK's bottom line. Meanwhile, the head of R&D becomes the top paid executive....Copyright 2013 WRAL Tech Wire. All rights reserved.
Glaxo CEO's pay package plunges 45% in 2012
1 comment | Post Yours
Print this blog postE-mail blog post
Share
Research Triangle Park, N.C. — GlaxoSmithKline's top executive Andrew Witty and the drug giant's chief financial officer take substantial reductions in compensation for 2012 as European market woes take a bite from GSK's bottom line. Meanwhile, the head of R&D becomes the top paid executive....Copyright 2013 WRAL Tech Wire. All rights reserved.
The Skinny
WRAL Local Tech Wire Publisher and Editor Rick Smith dishes out tidbits from the local technology sector. Read more articles…
| page 1 |
| page 1 |
Please Log In to add a comment.
Best of TechWire Insider
The Skinny
NC Biotech Center braces for worst as Senate slashes budget, too
ArchiveSocial, a new Durham success story, brings home international award
Durham's high-tech infrastructure, talent lure Virginia company
Lenovo acknowledges layoffs in Morrisville as part of shift to 'PC Plus' strategy
Raleigh-based PRA International eyes public offering
Will lightning strike again for veteran entrepreneur Brian Handly at StepLeader?
Raleigh app developer StepLeader lands $4.4M in first fund raiser
IBM opens Linux center in China, says it will work with Red Hat
Red-hot Raleigh startup WedPics hauls in $1.1M in funding
New Triangle venture capital firm slowly emerging from shadows














